Abstract:Background: Human induced pluripotent stem cells (hiPSCs) offer an unprecedented opportunity to generate a potentially unlimited source of cells to develop model systems that facilitate a mechanistic understanding of human disease. However, the predictive ability of hiPSC derived neurocardiac co-culture systems to recapitulate the human phenotype in diseased modelling is limited. Here, we optimized current methods for efficient and replicable induction of cardiac myocytes (hiPSC-CMs) and sympathetic neurons (hiPSC-SNs). The utility of healthy co-cultures was tested with pressor agents to develop a model of cardiac hypertrophy. Mono-cultures and co-cultures were also made from a patient with a catecholaminergic polymorphic ventricular tachycardia (CPVT) genotype (with isogenic pairing) to generate a model of triggered arrhythmia. Method: hiPSC-CMs and hiPSC-SNs were characterized by immunofluorescence, flow cytometry and calcium (Ca2+) imaging. Healthy hiPSC-CMs were incubated with angiotensin II (AngII) or endothelin-1 (ET-1) for 48 hours. Immunostaining, qPCR and ELISA were performed to measure cell size, pro-BNP expression and secretion in hypertrophic and control groups. cAMP was measured by Förster resonance energy transfer (FRET). Neurocardiac co-cultures were established by re-seeding spontaneously beating hiPSC-CMs (day 20) with mature hiPSC-SNs (day 40). Intracellular Ca2+ transients were measured in myocytes in response to isoprenaline, and in neurons in response to nicotinic stimulation. Results: Healthy hiPSC-SNs possessed neurite outgrowth, stained positive for PHOX2B, tyrosine hydroxylase and peripherin. Derived myocytes showed spontaneous beating, stained positive for cardiac troponin T and a-actinin. Cell surface area was significantly increased in older iPSC-CMs (day 40) (606.3±290.4μm2 vs 3299.8±967.9μm2, p<0.0001) compared to younger cells (day 20). Sarcomere length extended from 1.59μm to 1.88μm (p<0.0001). Healthy hiPSC-CMs exposed to AngII 0.1 μM (n=23), or ET-1 100nM (n=13) resulted in cell and nuclear enlargement, as well as enhanced proBNP gene expression and proBNP secretion. This overexpression was reversed by losartan in AngII treated cells. Cytoplasmic cAMP levels were increased by isoprenaline, which was higher in hypertrophic cells. CMs from the CPVT hiPSC line expressed a higher Ca2+ responsive to isoprenaline, caffeine and KCl stimulation when compared with healthy hiPSC-CMs. They also displayed spontaneous Ca2+ oscillations after isoprenaline. CPVT hiPSC-SNs had greater Ca2+ transients to nicotinic stimulation, indicating a diseased phenotype also resides in the neuron as well as the myocyte. Conclusion: We have recapitulated many features of the anatomy and (patho)physiology of SN and CM, where co-culture preparations behave in a manner that mimics key physiological responses seen in other mammalian systems. Whether our cell types have the full transcriptomic atlas of actual human cells remains to be established. CSC-COI Scholarship Programme, British Heart Foundation This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Transcriptional Variabilities in Human hiPSC-derived Cardiomyocytes: All Genes Are Not Equal and Their Robustness May Foretell Donor’s Disease Susceptibility

Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells.

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes

Personalized transcriptome signatures in a cardiomyopathy stem cell biobank

Human iPSC derived cardiac myocytes and sympathetic neurons in disease modelling

Transcriptomic Analysis of Cardiomyocyte Extracellular Vesicles in Hypertrophic Cardiomyopathy Reveals Differential snoRNA Cargo

Stem cell‐derived cardiomyocyte heterogeneity confounds electrophysiological insights

Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells

Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells

Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells

Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts

Lineage-specific regulatory changes in the pathological cardiac remodeling of hypertrophy cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics

The Low Tumorigenic Risk and Subtypes of Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells

Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling

Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues

Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics

iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects